Ann & Robert H. Lurie Children's Hospital of Chicago ( Site 0101)

Chicago, Illinois 60611

0 studies enrolling now · 1 studies all time

What they study most

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome

Studies at this site

• Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002) — Stopped early